Long-Acting β2-Agonists Increase Fluticasone Propionate-Induced Mitogen-Activated Protein Kinase Phosphatase 1 (MKP-1) in Airway Smooth Muscle Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Manetsch, Melanie ^a   Rahman, Md Mostafizur ^a   Patel, Brijeshkumar S ^a   Ramsay, Emma E ^a   Rumzhum, Nowshin N ^a   Alkhouri, Hatem ^a   Ge, Qi ^a   Ammit, Alaina J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; FORMOTEROL; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SALMETEROL; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHUS MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MONOTHERAPY; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; UPREGULATION;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANDROSTADIENES; BLOTTING, WESTERN; CELLS, CULTURED; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MYOCYTES, SMOOTH MUSCLE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84875330999     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059635     Document Type: Article

References (33)

1. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, et al. (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. New England Journal of Medicine 337: 1405-1411.
2. O'Byrne PM, Naya IP, Kallen A, Postma DS, Barnes PJ, (2008) Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control. Chest 134: 1192-1199.
3. Chung KF, Caramori G, Adcock IM, (2009) Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. European Journal of Clinical Pharmacology 65: 853-871.
4. Barnes PJ, (2011) Biochemical basis of asthma therapy. Journal of Biological Chemistry 286: 32899-32905.
5. Sun H, Charles CH, Lau LF, Tonks NK, (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487-493.
6. Clark AR, (2003) MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? Journal of Endocrinology 178: 5-12.
7. Kwak SP, Hakes DJ, Martell KJ, Dixon JE, (1994) Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. Journal of Biological Chemistry 269: 3596-3604.
8. Sommer A, Burkhardt H, Keyse SM, Luscher B, (2000) Synergistic activation of the mkp-1 gene by protein kinase A signaling and USF, but not c-Myc. FEBS Lett 474: 146-150.
9. Issa R, Xie S, Khorasani N, Sukkar M, Adcock IM, et al. (2007) Corticosteroid inhibition of growth-related oncogene protein-alpha via mitogen-activated kinase phosphatase-1 in airway smooth muscle cells. Journal of Immunology 178: 7366-7375.
10. Quante T, Ng YC, Ramsay EE, Henness S, Allen JC, et al. (2008) Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1. Am J Respir Cell Mol Biol 39: 208-217.
11. Kang BN, Jude JA, Panettieri RA Jr, Walseth TF, Kannan MS, (2008) Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1. Am J Physiol Lung Cell Mol Physiol 295: L186-193.
12. Kaur M, Chivers JE, Giembycz MA, Newton R, (2008) Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 73: 203-214.
13. King EM, Holden NS, Gong W, Rider CF, Newton R, (2009) Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. Journal of Biological Chemistry 284: 26803-26815.
14. Newton R, King EM, Gong W, Rider CF, Staples KJ, et al. (2010) Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1. Biochemical Journal 427: 113-124.
15. Manetsch M, Ramsay E, King E, Seidel P, Che W, et al. (2012) Corticosteroids and beta(2)-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms. British Journal of Pharmacology 166: 2049-2059.
16. Giembycz MA, Kaur M, Leigh R, Newton R, (2008) A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. British Journal of Pharmacology 153: 1090-1104.
17. Amrani Y, Ammit AJ, Panettieri RA Jr, (2001) Tumor Necrosis Factor Receptor (TNFR) 1, but Not TNFR2, Mediates Tumor Necrosis Factor-alpha-Induced Interleukin-6 and RANTES in Human Airway Smooth Muscle Cells: Role of p38 and p42/44 Mitogen-Activated Protein Kinases. Molecular Pharmacology 60: 646-655.
18. Henness S, van Thoor E, Ge Q, Armour CL, Hughes JM, et al. (2006) IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM. American Journal of Physiology 290: L1283-L1290.
19. Johnson PR, McKay KO, Armour CL, Black JL, (1995) The maintenance of functional activity in human isolated bronchus after cryopreservation. Pulmonary Pharmacology 8: 43-47.
20. Che W, Manetsch M, Quante T, Rahman MM, Patel BS, et al. (2012) Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells. Biochimica et Biophysica Acta 1823: 1658-1665.
21. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, et al. (2002) TNFα-induced secretion of RANTES and IL-6 from human airway smooth muscle cells: Modulation by glucocorticoids and β-agonists. American Journal of Respiratory Cell and Molecular Biology 26: 465-474.
22. Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, et al. (2001) Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB Journal 15: 1212-1214.
23. Ammit AJ, Hoffman RK, Amrani Y, Lazaar AL, Hay DWP, et al. (2000) TNFα-induced secretion of RANTES and IL-6 from human airway smooth muscle cells: Modulation by cAMP. American Journal of Respiratory Cell and Molecular Biology 23: 794-802.
24. Pang L, Knox AJ, (2000) Synergistic inhibition by β-agonists and corticosteroids on tumor necrosis factor-α-induced interleukin-8 release from cultured human airway smooth-muscle cells. American Journal of Respiratory Cell and Molecular Biology 23: 79-85.
25. Holden NS, Rider CF, Bell MJ, Velayudhan J, King EM, et al. (2010) Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. British Journal of Pharmacology 160: 410-420.
26. Roebuck KA, (1999) Regulation of interleukin-8 gene expression. Journal of Interferon and Cytokine Research 19: 429-438.
27. Essilfie-Quaye S, Ito K, Ito M, Kharitonov SA, Barnes PJ, (2011) Comparison of Symbicort(R) versus Pulmicort(R) on steroid pharmacodynamic markers in asthma patients. Respiratory Medicine 105: 1784-1789.
28. Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, et al. (2010) Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease. Journal of Pharmacology and Experimental Therapeutics 335: 788-798.
29. Carballo E, Lai WS, Blackshear PJ, (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005.
30. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, et al. (2001) Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Molecular and Cellular Biology 21: 6461-6469.
31. Tchen CR, Brook M, Saklatvala J, Clark AR, (2004) The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. Journal of Biological Chemistry 279: 32393-32400.
32. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, et al. (2006) Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Molecular and Cellular Biology 26: 2408-2418.
33. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, et al. (2006) Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Molecular and Cellular Biology 26: 2399-2407.